0001209191-20-037731.txt : 20200618 0001209191-20-037731.hdr.sgml : 20200618 20200618211927 ACCESSION NUMBER: 0001209191-20-037731 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200618 FILED AS OF DATE: 20200618 DATE AS OF CHANGE: 20200618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wellington Biomedical Innovation Master Investors (Cayman) I L.P. CENTRAL INDEX KEY: 0001787092 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39333 FILM NUMBER: 20974056 BUSINESS ADDRESS: STREET 1: WELLINGTON ALTERNATIVE INVESTMENTS LLC STREET 2: 280 CONGRESS STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (617) 951-5372 MAIL ADDRESS: STREET 1: WELLINGTON ALTERNATIVE INVESTMENTS LLC STREET 2: 280 CONGRESS STREET CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Forma Therapeutics Holdings, Inc., CENTRAL INDEX KEY: 0001538927 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 371657129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 ARSENAL STREET STREET 2: SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-679-1970 MAIL ADDRESS: STREET 1: 500 ARSENAL STREET STREET 2: SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: Forma Therapeutics Holdings LLC DATE OF NAME CHANGE: 20120106 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-06-18 0 0001538927 Forma Therapeutics Holdings, Inc., FMTX 0001787092 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210 0 0 1 0 Series D Convertible Preferred Stock Common Stock 1252913 D Each share of Series D Preferred Stock is convertible at any time, at the Reporting Person's election, into Common Stock, on a 4.2775-for-one basis into the number of shares of common stock shown in column 3, has no expiration date and will convert automatically into shares of Common Stock upon the closing of the Issuer's initial public offering. Wellington Biomedical Innovation Master Investors (Cayman) I L.P., By: Wellington Management Company LLP, as investment advisor, /s/ Matthew N. Shea, Title: Authorized Person 2020-06-18